AI Diagnostic Tool Analyzes CT Scans to Spot Prostate Cancer Before Patients Have Symptoms
By MedImaging International staff writers Posted on 13 Jul 2021 |
Image: AI Diagnostic Tool Analyzes CT Scans to Spot Prostate Cancer Before Patients Have Symptoms (Photo courtesy of RMIT University)
Researchers have developed a diagnostic tool that can spot prostate cancer before patients have any symptoms, using artificial intelligence to analyze Computed Tomography (CT) scans in just seconds.
Researchers at RMIT University (Melbourne, Australia), in collaboration with clinicians at St Vincent’s Hospital Melbourne (Australia), have developed an artificial intelligence (AI) program that could catch the prostate cancer earlier, allowing for incidental detection through routine CT scans. The technology works by analyzing CT scans for tell-tale signs of prostate cancer, something even a well-trained human eye struggles to do.
Prostate cancer is the most diagnosed cancer and is slow growing, usually detected incidentally due to which it can go undiagnosed for years. It was responsible for an estimated 12% of male cancer deaths in 2020. Early detection is the key to successful treatment but men often dodge the doctor, avoiding diagnosis tests until it’s too late. CT imaging is not suitable for regular cancer screening because of the high radiation doses involved. CT scans were great for detecting bone and joint problems but even radiologists struggled to spot prostate cancers on the images. The new AI solution can be used to run a cancer check whenever men have their abdomen or pelvis scanned for other issues.
For the study, the researchers studied CT scans of asymptomatic patients, with and without prostate cancer. The team trained the AI software to look for features of disease in a variety of scans and where exactly to look for them, avoiding the need to manually crop the images. The AI performed better than radiologists who viewed the same images, detecting cancerous growths in just seconds. What’s more, the AI improved with each scan, learning and adapting to read images from different machines to spot even the smallest irregularities. The technology can be applied at scale, potentially integrating with a variety of diagnostic imaging equipment like MRI and DEXA machines - pending further research.
“We’ve trained our software to see what the human eye can’t, with the aim of spotting prostate cancer through incidental detection,” said RMIT’s Dr. Ruwan Tennakoon. “It’s like training a sniffer dog – we can teach the AI to see things that we can't with our own eyes, in the same way a dog can smell things human noses can’t.”
Related Links:
RMIT University
St Vincent’s Hospital Melbourne
Researchers at RMIT University (Melbourne, Australia), in collaboration with clinicians at St Vincent’s Hospital Melbourne (Australia), have developed an artificial intelligence (AI) program that could catch the prostate cancer earlier, allowing for incidental detection through routine CT scans. The technology works by analyzing CT scans for tell-tale signs of prostate cancer, something even a well-trained human eye struggles to do.
Prostate cancer is the most diagnosed cancer and is slow growing, usually detected incidentally due to which it can go undiagnosed for years. It was responsible for an estimated 12% of male cancer deaths in 2020. Early detection is the key to successful treatment but men often dodge the doctor, avoiding diagnosis tests until it’s too late. CT imaging is not suitable for regular cancer screening because of the high radiation doses involved. CT scans were great for detecting bone and joint problems but even radiologists struggled to spot prostate cancers on the images. The new AI solution can be used to run a cancer check whenever men have their abdomen or pelvis scanned for other issues.
For the study, the researchers studied CT scans of asymptomatic patients, with and without prostate cancer. The team trained the AI software to look for features of disease in a variety of scans and where exactly to look for them, avoiding the need to manually crop the images. The AI performed better than radiologists who viewed the same images, detecting cancerous growths in just seconds. What’s more, the AI improved with each scan, learning and adapting to read images from different machines to spot even the smallest irregularities. The technology can be applied at scale, potentially integrating with a variety of diagnostic imaging equipment like MRI and DEXA machines - pending further research.
“We’ve trained our software to see what the human eye can’t, with the aim of spotting prostate cancer through incidental detection,” said RMIT’s Dr. Ruwan Tennakoon. “It’s like training a sniffer dog – we can teach the AI to see things that we can't with our own eyes, in the same way a dog can smell things human noses can’t.”
Related Links:
RMIT University
St Vincent’s Hospital Melbourne
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures